Lrrk2 Mouse (S)-naringenin decreases expression ISO RGD:1561168 6480464 naringenin results in decreased expression of LRRK2 mRNA CTD PMID:34655599 Lrrk2 Mouse (S)-naringenin multiple interactions ISO RGD:1561168 6480464 naringenin inhibits the reaction [Paraquat results in decreased expression of LRRK2 mRNA] CTD PMID:34655599 Lrrk2 Mouse 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of LRRK2 mRNA CTD PMID:26682919 Lrrk2 Mouse 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRRK2 mRNA CTD PMID:22206623 Lrrk2 Mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 HOTAIR affects the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of LRRK2 protein] CTD PMID:32968928 Lrrk2 Mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression EXP 6480464 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of LRRK2 protein CTD PMID:32968928 Lrrk2 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1561168 6480464 Tetrachlorodibenzodioxin affects the expression of LRRK2 mRNA CTD PMID:22298810 Lrrk2 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1561168 6480464 Tetrachlorodibenzodioxin results in decreased expression of LRRK2 mRNA CTD PMID:33387578 Lrrk2 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LRRK2 mRNA CTD PMID:33956508 Lrrk2 Mouse 3-methyladenine multiple interactions ISO RGD:1353141 6480464 3-methyladenine inhibits the reaction [LRRK2 gene mutant form results in increased susceptibility to 1-Methyl-4-phenylpyridinium] CTD PMID:25017139 Lrrk2 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of LRRK2 mRNA CTD PMID:28973697 Lrrk2 Mouse 6-propyl-2-thiouracil decreases expression ISO RGD:1561168 6480464 Propylthiouracil results in decreased expression of LRRK2 mRNA CTD PMID:24780913 Lrrk2 Mouse acetamide increases expression ISO RGD:1561168 6480464 acetamide results in increased expression of LRRK2 mRNA CTD PMID:31881176 Lrrk2 Mouse acrylamide multiple interactions EXP 6480464 Acrylamide promotes the reaction [NFATC2 protein binds to LRRK2 protein]; Acrylamide results in increased expression more ... CTD PMID:37037409 Lrrk2 Mouse acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of LRRK2 mRNA; Acrylamide results in increased expression of LRRK2 more ... CTD PMID:37037409 Lrrk2 Mouse aflatoxin B1 decreases methylation ISO RGD:1353141 6480464 Aflatoxin B1 results in decreased methylation of LRRK2 gene CTD PMID:27153756 Lrrk2 Mouse Aflatoxin B2 alpha increases methylation ISO RGD:1353141 6480464 aflatoxin B2 results in increased methylation of LRRK2 intron CTD PMID:30157460 Lrrk2 Mouse all-trans-retinoic acid increases expression ISO RGD:1353141 6480464 Tretinoin results in increased expression of LRRK2 mRNA CTD PMID:33167477 Lrrk2 Mouse amphetamine increases expression ISO RGD:1561168 6480464 Amphetamine results in increased expression of LRRK2 mRNA CTD PMID:30779732 Lrrk2 Mouse antimony(0) decreases expression ISO RGD:1353141 6480464 Antimony results in decreased expression of LRRK2 protein CTD PMID:38097005 Lrrk2 Mouse antimony(0) multiple interactions ISO RGD:1353141 6480464 MCOLN1 protein inhibits the reaction [Antimony results in decreased expression of LRRK2 protein] CTD PMID:38097005 Lrrk2 Mouse arsenite(3-) increases phosphorylation EXP 6480464 arsenite results in increased phosphorylation of LRRK2 protein CTD PMID:33053406 Lrrk2 Mouse bafilomycin A1 increases response to substance ISO RGD:1353141 6480464 LRRK2 gene mutant form results in increased susceptibility to bafilomycin A1 CTD PMID:25017139 Lrrk2 Mouse benzo[a]pyrene decreases expression ISO RGD:1561168 6480464 Benzo(a)pyrene results in decreased expression of LRRK2 mRNA CTD PMID:21839799 Lrrk2 Mouse benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of LRRK2 intron CTD PMID:27901495 Lrrk2 Mouse benzo[a]pyrene affects methylation ISO RGD:1353141 6480464 Benzo(a)pyrene affects the methylation of LRRK2 intron CTD PMID:30157460 Lrrk2 Mouse benzo[e]pyrene increases methylation ISO RGD:1353141 6480464 benzo(e)pyrene results in increased methylation of LRRK2 intron CTD PMID:30157460 Lrrk2 Mouse bisphenol A increases methylation ISO RGD:1561168 6480464 bisphenol A results in increased methylation of LRRK2 gene CTD PMID:28505145 Lrrk2 Mouse bisphenol A decreases methylation ISO RGD:1353141 6480464 bisphenol A results in decreased methylation of LRRK2 gene CTD PMID:31601247 Lrrk2 Mouse bisphenol A decreases expression ISO RGD:1561168 6480464 bisphenol A results in decreased expression of LRRK2 mRNA CTD PMID:34947998 Lrrk2 Mouse bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LRRK2 mRNA CTD PMID:33221593 Lrrk2 Mouse butanal decreases expression ISO RGD:1353141 6480464 butyraldehyde results in decreased expression of LRRK2 mRNA CTD PMID:26079696 Lrrk2 Mouse cadmium atom decreases expression ISO RGD:1353141 6480464 Cadmium results in decreased expression of LRRK2 mRNA CTD PMID:21120746 Lrrk2 Mouse cadmium atom multiple interactions ISO RGD:1561168 6480464 Acetylcysteine inhibits the reaction [Cadmium results in increased expression of LRRK2 mRNA] CTD PMID:34816377 Lrrk2 Mouse cadmium atom increases expression ISO RGD:1561168 6480464 Cadmium results in increased expression of LRRK2 mRNA CTD PMID:34816377 Lrrk2 Mouse cadmium atom multiple interactions ISO RGD:1353141 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRRK2 more ... CTD PMID:35301059 Lrrk2 Mouse cadmium dichloride multiple interactions ISO RGD:1353141 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRRK2 more ... CTD PMID:35301059 Lrrk2 Mouse carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of LRRK2 mRNA; Nanotubes, Carbon results in increased more ... CTD PMID:25554681 Lrrk2 Mouse CGP 52608 multiple interactions ISO RGD:1353141 6480464 CGP 52608 promotes the reaction [RORA protein binds to LRRK2 gene] CTD PMID:28238834 Lrrk2 Mouse chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of LRRK2 mRNA CTD PMID:29156651|PMID:37019170 Lrrk2 Mouse cisplatin decreases expression ISO RGD:1353141 6480464 Cisplatin results in decreased expression of LRRK2 mRNA CTD PMID:27392435 Lrrk2 Mouse cisplatin multiple interactions ISO RGD:1353141 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of LRRK2 mRNA CTD PMID:27392435 Lrrk2 Mouse clozapine increases expression ISO RGD:1353141 6480464 Clozapine results in increased expression of LRRK2 protein CTD PMID:34122009 Lrrk2 Mouse copper(II) sulfate affects expression ISO RGD:1353141 6480464 Copper Sulfate affects the expression of LRRK2 mRNA CTD PMID:19549813 Lrrk2 Mouse corticosterone increases secretion EXP 6480464 LRRK2 protein mutant form results in increased secretion of Corticosterone; LRRK2 protein results in increased more ... CTD PMID:31174552 Lrrk2 Mouse corticosterone multiple interactions EXP 6480464 LRRK2 protein mutant form promotes the reaction [Paraquat results in increased secretion of Corticosterone] CTD PMID:31174552 Lrrk2 Mouse crocidolite asbestos decreases expression EXP 6480464 Asbestos, Crocidolite results in decreased expression of LRRK2 mRNA CTD PMID:29279043 Lrrk2 Mouse DDE decreases expression ISO RGD:1353141 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of LRRK2 mRNA CTD PMID:38568856 Lrrk2 Mouse Dibutyl phosphate affects expression ISO RGD:1353141 6480464 di-n-butylphosphoric acid affects the expression of LRRK2 mRNA CTD PMID:37042841 Lrrk2 Mouse dimethylarsinic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Lrrk2 Mouse dioxygen increases expression ISO RGD:1353141 6480464 Oxygen deficiency results in increased expression of LRRK2 mRNA CTD PMID:26516004 Lrrk2 Mouse dopamine multiple interactions ISO RGD:1353141 6480464 LRRK2 mutant form results in increased susceptibility to [Dopamine co-treated with SLC6A3 protein] CTD PMID:23628791 Lrrk2 Mouse dorsomorphin multiple interactions ISO RGD:1353141 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Lrrk2 Mouse doxorubicin decreases expression ISO RGD:1353141 6480464 Doxorubicin results in decreased expression of LRRK2 mRNA CTD PMID:29803840 Lrrk2 Mouse endosulfan affects expression ISO RGD:1561168 6480464 Endosulfan affects the expression of LRRK2 mRNA CTD PMID:29391264 Lrrk2 Mouse ethanol affects splicing EXP 6480464 Ethanol affects the splicing of LRRK2 mRNA CTD PMID:30319688 Lrrk2 Mouse ethanol affects expression EXP 6480464 Ethanol affects the expression of LRRK2 mRNA CTD PMID:30319688 Lrrk2 Mouse ethyl methanesulfonate increases expression ISO RGD:1353141 6480464 Ethyl Methanesulfonate results in increased expression of LRRK2 mRNA CTD PMID:23649840 Lrrk2 Mouse fenamidone increases expression EXP 6480464 fenamidone results in increased expression of LRRK2 mRNA CTD PMID:27029645 Lrrk2 Mouse folic acid multiple interactions EXP 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRRK2 mRNA CTD PMID:22206623 Lrrk2 Mouse furan increases expression ISO RGD:1561168 6480464 furan results in increased expression of LRRK2 mRNA CTD PMID:27387713 Lrrk2 Mouse gentamycin increases expression ISO RGD:1561168 6480464 Gentamicins results in increased expression of LRRK2 mRNA CTD PMID:33387578 Lrrk2 Mouse GTP multiple interactions ISO RGD:1353141 6480464 sodium arsenite inhibits the reaction [LRRK2 protein binds to Guanosine Triphosphate] CTD PMID:24942733 Lrrk2 Mouse GTP affects binding ISO RGD:1353141 6480464 LRRK2 protein binds to Guanosine Triphosphate CTD PMID:24942733 Lrrk2 Mouse hydrogen peroxide increases response to substance EXP 6480464 LRRK2 protein results in increased susceptibility to Hydrogen Peroxide CTD PMID:19692353 Lrrk2 Mouse hydrogen peroxide decreases phosphorylation ISO RGD:1353141 6480464 Hydrogen Peroxide results in decreased phosphorylation of LRRK2 protein; Hydrogen Peroxide results in decreased phosphorylation more ... CTD PMID:24942733 Lrrk2 Mouse lactacystin increases ubiquitination ISO RGD:1353141 6480464 lactacystin results in increased ubiquitination of LRRK2 protein CTD PMID:24942733 Lrrk2 Mouse lead(0) increases expression ISO RGD:1561168 6480464 Lead results in increased expression of LRRK2 mRNA CTD PMID:34816377 Lrrk2 Mouse lead(0) multiple interactions ISO RGD:1561168 6480464 Acetylcysteine inhibits the reaction [Lead results in increased expression of LRRK2 mRNA] CTD PMID:34816377 Lrrk2 Mouse lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of LRRK2 mRNA; Lipopolysaccharides results in increased expression of LRRK2 more ... CTD PMID:30720180 Lrrk2 Mouse lipopolysaccharide multiple interactions ISO RGD:1353141 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRK2 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... CTD PMID:35811015 Lrrk2 Mouse lipopolysaccharide decreases expression ISO RGD:1353141 6480464 Lipopolysaccharides results in decreased expression of LRRK2 mRNA CTD PMID:35811015 Lrrk2 Mouse lipopolysaccharide multiple interactions EXP 6480464 LRRK2 protein affects the reaction [Lipopolysaccharides results in decreased expression of SLC6A3 protein]; LRRK2 protein more ... CTD PMID:32247534 Lrrk2 Mouse luteolin multiple interactions EXP 6480464 [Rotenone co-treated with Luteolin] results in increased expression of LRRK2 mRNA; Luteolin inhibits the reaction more ... CTD PMID:30207190 Lrrk2 Mouse maneb multiple interactions EXP 6480464 [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of more ... CTD PMID:23017109 Lrrk2 Mouse maneb multiple interactions ISO RGD:1353141 6480464 3-(4-(morpholin-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-5-yl)benzonitrile inhibits the reaction [[Paraquat co-treated with Maneb] results in increased phosphorylation of LRRK2 protein]; more ... CTD PMID:34897981 Lrrk2 Mouse manganese atom multiple interactions ISO RGD:1353141 6480464 LRRK2 mutant form results in increased susceptibility to [Manganese co-treated with SLC6A3 protein] CTD PMID:23628791 Lrrk2 Mouse manganese atom increases response to substance ISO RGD:1353141 6480464 LRRK2 mutant form results in increased susceptibility to Manganese CTD PMID:23628791 Lrrk2 Mouse manganese(0) increases response to substance ISO RGD:1353141 6480464 LRRK2 mutant form results in increased susceptibility to Manganese CTD PMID:23628791 Lrrk2 Mouse manganese(0) multiple interactions ISO RGD:1353141 6480464 LRRK2 mutant form results in increased susceptibility to [Manganese co-treated with SLC6A3 protein] CTD PMID:23628791 Lrrk2 Mouse methapyrilene increases methylation ISO RGD:1353141 6480464 Methapyrilene results in increased methylation of LRRK2 intron CTD PMID:30157460 Lrrk2 Mouse methoxychlor affects methylation ISO RGD:1561168 6480464 Methoxychlor affects the methylation of LRRK2 gene CTD PMID:35440735 Lrrk2 Mouse methylarsonic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Lrrk2 Mouse N,N-diethyl-m-toluamide multiple interactions ISO RGD:1561168 6480464 [Permethrin co-treated with DEET] results in increased methylation of LRRK2 gene CTD PMID:33148267 Lrrk2 Mouse N-acetyl-L-cysteine multiple interactions ISO RGD:1353141 6480464 Acetylcysteine inhibits the reaction [[Paraquat co-treated with Maneb] results in increased phosphorylation of LRRK2 protein] CTD PMID:34897981 Lrrk2 Mouse N-acetyl-L-cysteine multiple interactions ISO RGD:1561168 6480464 Acetylcysteine inhibits the reaction [Cadmium results in increased expression of LRRK2 mRNA]; Acetylcysteine inhibits the more ... CTD PMID:34816377 Lrrk2 Mouse N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases ubiquitination ISO RGD:1353141 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of LRRK2 protein CTD PMID:24942733 Lrrk2 Mouse N-methyl-4-phenylpyridinium increases response to substance ISO RGD:1353141 6480464 LRRK2 gene mutant form results in increased susceptibility to 1-Methyl-4-phenylpyridinium; LRRK2 protein mutant form results more ... CTD PMID:25017139|PMID:26930193 Lrrk2 Mouse N-methyl-4-phenylpyridinium increases expression ISO RGD:1353141 6480464 1-Methyl-4-phenylpyridinium results in increased expression of LRRK2 mRNA; 1-Methyl-4-phenylpyridinium results in increased expression of LRRK2 more ... CTD PMID:30720180|PMID:35773961 Lrrk2 Mouse N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1353141 6480464 1-Methyl-4-phenylpyridinium promotes the reaction [LRRK2 gene mutant form results in increased activity of CASP3 protein]; more ... CTD PMID:25017139|PMID:26930193|PMID:30720180|PMID:35773961 Lrrk2 Mouse nickel atom decreases expression ISO RGD:1353141 6480464 Nickel results in decreased expression of LRRK2 mRNA CTD PMID:23195993 Lrrk2 Mouse okadaic acid decreases expression ISO RGD:1353141 6480464 Okadaic Acid results in decreased expression of LRRK2 mRNA CTD PMID:38832940 Lrrk2 Mouse paracetamol decreases expression ISO RGD:1353141 6480464 Acetaminophen results in decreased expression of LRRK2 mRNA CTD PMID:29067470 Lrrk2 Mouse paracetamol decreases expression ISO RGD:1561168 6480464 Acetaminophen results in decreased expression of LRRK2 mRNA CTD PMID:33387578 Lrrk2 Mouse paraquat decreases response to substance ISO RGD:1353141 6480464 LRRK2 protein mutant form results in decreased susceptibility to Paraquat; LRRK2 protein results in decreased more ... CTD PMID:19625511|PMID:26020005 Lrrk2 Mouse paraquat multiple interactions ISO RGD:1561168 6480464 naringenin inhibits the reaction [Paraquat results in decreased expression of LRRK2 mRNA] CTD PMID:34655599 Lrrk2 Mouse paraquat decreases expression ISO RGD:1561168 6480464 Paraquat results in decreased expression of LRRK2 mRNA CTD PMID:34655599 Lrrk2 Mouse paraquat multiple interactions ISO RGD:1353141 6480464 3-(4-(morpholin-4-yl)-7H-pyrrolo(2,3-d)pyrimidin-5-yl)benzonitrile inhibits the reaction [[Paraquat co-treated with Maneb] results in increased phosphorylation of LRRK2 protein]; more ... CTD PMID:34897981 Lrrk2 Mouse paraquat affects response to substance EXP 6480464 LRRK2 protein affects the susceptibility to Paraquat CTD PMID:32247534 Lrrk2 Mouse paraquat increases response to substance EXP 6480464 LRRK2 protein results in increased susceptibility to Paraquat CTD PMID:31174552 Lrrk2 Mouse paraquat multiple interactions EXP 6480464 [LRRK2 protein mutant form co-treated with Maneb co-treated with Paraquat] results in decreased expression of more ... CTD PMID:23017109|PMID:31174552|PMID:32247534 Lrrk2 Mouse pentanal decreases expression ISO RGD:1353141 6480464 pentanal results in decreased expression of LRRK2 mRNA CTD PMID:26079696 Lrrk2 Mouse perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of LRRK2 mRNA CTD PMID:37995155 Lrrk2 Mouse perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1353141 6480464 perfluorooctane sulfonic acid results in decreased expression of LRRK2 mRNA CTD PMID:27153767 Lrrk2 Mouse permethrin multiple interactions ISO RGD:1561168 6480464 [Permethrin co-treated with DEET] results in increased methylation of LRRK2 gene CTD PMID:33148267 Lrrk2 Mouse pirinixic acid multiple interactions ISO RGD:1353141 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Lrrk2 Mouse pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of LRRK2 mRNA CTD PMID:20813756 Lrrk2 Mouse resveratrol multiple interactions ISO RGD:1353141 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of LRRK2 mRNA CTD PMID:23557933 Lrrk2 Mouse rotenone decreases response to substance ISO RGD:1353141 6480464 LRRK2 protein results in decreased susceptibility to Rotenone CTD PMID:19625511|PMID:20067578 Lrrk2 Mouse rotenone multiple interactions EXP 6480464 [Rotenone co-treated with Luteolin] results in increased expression of LRRK2 mRNA; Luteolin inhibits the reaction more ... CTD PMID:30207190 Lrrk2 Mouse rotenone increases expression EXP 6480464 Rotenone results in increased expression of LRRK2 mRNA CTD PMID:30207190 Lrrk2 Mouse rotenone affects expression ISO RGD:1561168 6480464 Rotenone affects the expression of LRRK2 mRNA CTD PMID:31814881 Lrrk2 Mouse rotenone multiple interactions ISO RGD:1353141 6480464 PMK-1 protein affects the reaction [LRRK2 protein results in decreased susceptibility to Rotenone]; PRKN protein more ... CTD PMID:19741132|PMID:20067578 Lrrk2 Mouse rotenone increases response to substance ISO RGD:1353141 6480464 LRRK2 gene polymorphism results in increased susceptibility to Rotenone; LRRK2 protein results in increased susceptibility more ... CTD PMID:19692353|PMID:19741132 Lrrk2 Mouse S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1353141 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRK2 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... CTD PMID:35811015 Lrrk2 Mouse SB 431542 multiple interactions ISO RGD:1353141 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Lrrk2 Mouse sodium arsenate multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Lrrk2 Mouse sodium arsenite multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Lrrk2 Mouse sodium arsenite decreases phosphorylation ISO RGD:1353141 6480464 sodium arsenite results in decreased phosphorylation of LRRK2 protein mutant form CTD PMID:24942733 Lrrk2 Mouse sodium arsenite multiple interactions ISO RGD:1353141 6480464 sodium arsenite inhibits the reaction [LRRK2 protein binds to Guanosine Triphosphate]; sodium arsenite inhibits the more ... CTD PMID:24942733 Lrrk2 Mouse sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of LRRK2 mRNA CTD PMID:30529165 Lrrk2 Mouse sunitinib decreases expression ISO RGD:1353141 6480464 Sunitinib results in decreased expression of LRRK2 mRNA CTD PMID:31533062 Lrrk2 Mouse thioacetamide increases expression ISO RGD:1561168 6480464 Thioacetamide results in increased expression of LRRK2 mRNA CTD PMID:34492290 Lrrk2 Mouse titanium dioxide increases methylation ISO RGD:1353141 6480464 titanium dioxide results in increased methylation of LRRK2 promoter CTD PMID:34973136 Lrrk2 Mouse trichloroethene multiple interactions ISO RGD:1561168 6480464 Trichloroethylene results in increased activity of and results in increased phosphorylation of LRRK2 protein CTD PMID:33636387 Lrrk2 Mouse trichostatin A increases expression ISO RGD:1353141 6480464 trichostatin A results in increased expression of LRRK2 mRNA CTD PMID:24935251 Lrrk2 Mouse trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of LRRK2 mRNA CTD PMID:19042947 Lrrk2 Mouse triphenyl phosphate affects expression ISO RGD:1353141 6480464 triphenyl phosphate affects the expression of LRRK2 mRNA CTD PMID:37042841 Lrrk2 Mouse tris(2-butoxyethyl) phosphate affects expression ISO RGD:1353141 6480464 tris(2-butoxyethyl) phosphate affects the expression of LRRK2 mRNA CTD PMID:29024780 Lrrk2 Mouse trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of LRRK2 mRNA CTD PMID:35537566 Lrrk2 Mouse tungsten decreases expression EXP 6480464 Tungsten results in decreased expression of LRRK2 mRNA CTD PMID:30912803 Lrrk2 Mouse valproic acid decreases methylation ISO RGD:1353141 6480464 Valproic Acid results in decreased methylation of LRRK2 gene CTD PMID:29154799 Lrrk2 Mouse valproic acid increases expression ISO RGD:1353141 6480464 Valproic Acid results in increased expression of LRRK2 mRNA CTD PMID:26272509 Lrrk2 Mouse valproic acid multiple interactions ISO RGD:1353141 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Lrrk2 Mouse zoledronic acid decreases expression ISO RGD:1353141 6480464 zoledronic acid results in decreased expression of LRRK2 mRNA CTD PMID:24714768